Valley National Advisers’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.34K | Hold |
108
| – | – | ﹤0.01% | 656 |
|
|
2026
Q1 | $7K | Sell |
108
-24
| -18% | -$1.77K | ﹤0.01% | 653 |
|
|
2025
Q4 | $9K | Hold |
132
| – | – | ﹤0.01% | 623 |
|
|
2025
Q3 | $8K | Hold |
132
| – | – | ﹤0.01% | 606 |
|
|
2025
Q2 | $8K | Sell |
132
-125
| -49% | -$7.96K | ﹤0.01% | 601 |
|
|
2025
Q1 | $17K | Buy |
257
+125
| +95% | +$8.58K | ﹤0.01% | 500 |
|
|
2024
Q4 | $8K | Hold |
132
| – | – | ﹤0.01% | 571 |
|
|
2024
Q3 | $9K | Hold |
132
| – | – | ﹤0.01% | 533 |
|
|
2024
Q2 | $9K | Hold |
132
| – | – | ﹤0.01% | 643 |
|
|
2024
Q1 | $9K | Sell |
132
-54
| -29% | -$3.66K | ﹤0.01% | 662 |
|
|
2023
Q4 | $12K | Sell |
186
-7,242
| -97% | -$442K | ﹤0.01% | 619 |
|
|
2023
Q3 | $450K | Sell |
7,428
-156
| -2% | -$9.8K | 0.08% | 169 |
|
|
2023
Q2 | $480K | Sell |
7,584
-48
| -0.6% | -$3.01K | 0.08% | 173 |
|
|
2023
Q1 | $489K | Buy |
7,632
+326
| +4% | +$20.2K | 0.09% | 170 |
|
|
2022
Q4 | $467K | Sell |
7,306
-448
| -6% | -$28K | 0.08% | 176 |
|
|
2022
Q3 | $465K | Buy |
7,754
+7,601
| +4,968% | +$467K | 0.1% | 170 |
|
|
2022
Q2 | $10K | Hold |
153
| – | – | ﹤0.01% | 567 |
|
|
2022
Q1 | $10K | Hold |
153
| – | – | ﹤0.01% | 601 |
|
|
2021
Q4 | $11K | Hold |
153
| – | – | ﹤0.01% | 584 |
|
|
2021
Q3 | $10K | Hold |
153
| – | – | ﹤0.01% | 579 |
|
|
2021
Q2 | $10K | Hold |
153
| – | – | ﹤0.01% | 581 |
|
|
2021
Q1 | $9K | Hold |
153
| – | – | ﹤0.01% | 552 |
|
|
2020
Q4 | $9K | Hold |
153
| – | – | ﹤0.01% | 531 |
|
|
2020
Q3 | $8K | Hold |
153
| – | – | ﹤0.01% | 503 |
|
|
2020
Q2 | $8K | Sell |
153
-84
| -35% | -$4.07K | ﹤0.01% | 500 |
|
|
2020
Q1 | $10K | Sell |
237
-70
| -23% | -$3.32K | ﹤0.01% | 465 |
|
|
2019
Q4 | $15K | Hold |
307
| – | – | ﹤0.01% | 473 |
|
|
2019
Q3 | $13K | Hold |
307
| – | – | ﹤0.01% | 481 |
|
|
2019
Q2 | $14K | Hold |
307
| – | – | ﹤0.01% | 446 |
|
|
2019
Q1 | $14K | Hold |
307
| – | – | ﹤0.01% | 443 |
|
|
2018
Q4 | $13K | Hold |
307
| – | – | ﹤0.01% | 417 |
|
|
2018
Q3 | $14K | Hold |
307
| – | – | ﹤0.01% | 402 |
|
|
2018
Q2 | $13K | Hold |
307
| – | – | 0.01% | 390 |
|
|
2018
Q1 | $12K | Hold |
307
| – | – | ﹤0.01% | 384 |
|
|
2017
Q4 | $12K | Hold |
307
| – | – | ﹤0.01% | 385 |
|
|
2017
Q3 | $12K | Hold |
307
| – | – | ﹤0.01% | 383 |
|
|
2017
Q2 | $12K | Hold |
307
| – | – | ﹤0.01% | 382 |
|
|
2017
Q1 | $11K | Hold |
307
| – | – | ﹤0.01% | 393 |
|
|
2016
Q4 | $10K | Hold |
307
| – | – | ﹤0.01% | 404 |
|
|
2016
Q3 | $11K | Hold |
307
| – | – | 0.01% | 371 |
|
|
2016
Q2 | $10K | Hold |
307
| – | – | 0.01% | 385 |
|
|
2016
Q1 | $10K | Hold |
307
| – | – | 0.01% | 380 |
|
|
2015
Q4 | $11K | Buy |
+307
| New | +$10.4K | 0.01% | 363 |
|
Other funds holding FHLC
AWM
AM
WAM
Valley National Advisers's FHLC Position: Q2 2026 in Review
Valley National Advisers held its Fidelity MSCI Health Care Index ETF (FHLC) position steady in Q2 2026 at 108 shares worth $8.34K. The position accounts for ﹤0.01% of the portfolio, ranked #656.
Valley National Advisers first reported a position in FHLC in Q4 2015 and has held it in 43 quarters since. The position peaked at $489K in Q1 2023. 385 funds tracked by Wall St. Rank hold FHLC as of Q2 2026.
- Valley National Advisers held 108 shares of Fidelity MSCI Health Care Index ETF worth $8.34K as of Q2 2026.
- Valley National Advisers left its Fidelity MSCI Health Care Index ETF share count unchanged in Q2 2026.
- Fidelity MSCI Health Care Index ETF made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #656 holding.
- Valley National Advisers first reported a position in Fidelity MSCI Health Care Index ETF in Q4 2015 and has held it in 43 quarters since.
- Valley National Advisers's Fidelity MSCI Health Care Index ETF position peaked at $489K in Q1 2023.
- 385 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.